Mastitis Prevention and Dairy Cow Welfare

How mastitis prevention programmes protect dairy cow welfare and reduce suffering in commercial herds.

Key Facts

Mastitis is the most common and economically costly disease in dairy cattle worldwide
Affected cows experience significant pain, reduced milk production, and systemic illness in severe cases
Subclinical mastitis causes chronic discomfort without visible signs, affecting many more cows than clinical disease
Prevention through milking hygiene, dry cow therapy, and teat condition monitoring is highly effective
Antibiotic-free dry cow therapy is possible in low SCC herds with appropriate teat sealant use
Chronic mastitis is a leading reason for early culling of dairy cows, representing welfare and production failure

Welfare Considerations

Mastitis causes genuine and significant pain, particularly in its clinical forms where the udder is hot, swollen, and engorged. Even subclinical mastitis — detectable only through milk testing — involves ongoing udder inflammation and discomfort. The scale of mastitis in dairy production makes it one of the highest-volume welfare problems in farming globally. Prevention-focused herd health plans that invest in hygiene, monitoring, and appropriate treatment protocols protect both cow welfare and the long-term viability of the herd. Welfare and production incentives are strongly aligned in mastitis management.

What You Can Do

Support dairy operations that publish somatic cell counts and mastitis incidence as welfare indicators
Advocate for mastitis prevention as a core requirement in dairy welfare certification schemes
Choose dairy products from farms with documented low mastitis prevalence and prompt treatment protocols
Encourage veterinary herd health programmes that prioritize mastitis prevention over reactive treatment
Support research into non-antibiotic mastitis prevention tools that maintain welfare without increasing resistance